+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Apheresis Market By: Product Type, Application, Technology, and Region - Forecast up to 2026

  • ID: 5187549
  • Report
  • July 2020
  • Region: Global
  • 125 pages
  • Infoholic Research LLP
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cerus Corporation
  • Haemonetics Corporation
  • LMB Technologie GmbH
  • Medica Spa
  • Nikkiso Co., Ltd.
  • MORE
Apheresis is a medical procedure which deals with removing the blood from the body of a patient or donor, for separating some required individual components from it while simultaneously re- introduces the remaining blood into the body of the donor or patient.

Research Methodology:

The apheresis market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study.

The apheresis market is expected to grow at a CAGR of ~7.7% during the forecast period 2019–2026. The expansion of this market can be attributed to the rise in the prevalence of chronic diseases, increase in the surgical procedures and the growing cases of accident or injury. However, the market is constrained by the high cost of its procedures, lack of skilled professionals and its awareness especially in the under-developed countries. The ongoing pandemic duly points out to the dire need of investment in the healthcare sector. The treatment by the transfusion with convalescent plasma has resurfaced to fight this deadly disease due to its potential merits. There is an empirical data available on its benefits and the high potential of this method in the health industry.

The scope of Apheresis market is defined by products devices, applications, procedure, technology and region. The following report closely analyses this trend in this market by capturing details of the investment, growth opportunities, and government initiatives in the upcoming years. The focus is also on some key challenges and their impact on the market. Therefore, it is a useful tool for the key stakeholders study this market comprehensively.

Based on product, the apheresis market is divided into:
  • Devices
  • Disposables
Disposables had the higher market share in 2019 and are anticipated to maintain this throughout the forecast period because of substantial progress in the manufacturing of blood bags, tubing sets, filters, kits and various instruments and separators. The market of apheresis devices is growing consistently but at a relatively slower rate. There has been increasing efficiency in the ability to separate all types of blood components through therapeutics procedure.

Applications used in apheresis includes:
  • Plasmapheresis
  • Plateletpheresis
  • Erythrocytapheresis
  • Leukapheresis
  • Photopheresis
Plasmapheresis which is a process to separate plasma, white blood cells, red blood cells and platelets, had the largest share in the market in 2019 due to the rise in blood-related disorders and growing demand for plasma- derived medicines.

On the basis of technology, it can be categorized under:
  • Membrane Filtration
  • Centrifugation
These machine functions are used to separate various blood components. Membrane filters are useful in filtration of plasma from other components such as white blood cells, red blood cells and platelets However, in centrifugation, specific cells are separated by the use of gravity. This method is less time consuming and is highly used in Western European regions and Japan. In 2019, it produced maximum revenues in Apheresis market majorly due to its maximum use in hospitals.

On the basis of methods, the market is divided into:
  • Automated Blood Collection
  • Therapeutic Apheresis
It is done by extracting individual components such as platelets or plasma from the blood of the donor. In therapy, the purpose is to remove the defective disease-causing cells from the body of the patient. The rising instances of cardiovascular and neurological diseases, blood cancer etc are key factors in the rise of apheresis markets.

Based on region, the market is divided among four key regions of:
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
North America holds the largest share of the apheresis equipment market in as it has one of the world’s advanced healthcare facilities and high healthcare expenditure. The Asian Pacific regional market is expected to grow in the period due to the increase in the diseases requiring blood transfusion and the growing market and infrastructure for healthcare facilities. Also, the government expenditure on healthcare is expected to rise especially in India which aims at bringing it to 2.5 % in 2025.

However, there is much scope of improvement globally as the initial investment in this market is high and its maintenance cost is high. Nevertheless, we see the market is booming with key providers operating in the global apheresis market including:
  • Kaneka Corporation
  • LMB Technologie GmbH
  • Medica S.p.a
  • Miltenyi Biotec
The market is highly competitive due to advancing technology, various global government initiatives to generate knowledge, and various companies deploying strategies to commercialize their products.

This report will be delivered within 3-5 business days.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cerus Corporation
  • Haemonetics Corporation
  • LMB Technologie GmbH
  • Medica Spa
  • Nikkiso Co., Ltd.
  • MORE

1. Executive Summary

2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends

3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.3. PEST Analysis
3.4. Porter Five Forces
3.5. Related Markets

4. Market Characterisitics
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis

5. Product: Market Size & Analysis
5.1. Overview
5.2. Devices
5.3. Disposables

6. Application: Market Size & Analysis
6.1. Overview
6.2. Plasmapheresis
6.3. Plateletpheresis
6.4. Erythrocytapheresis
6.5. Leukapheresis
6.6. Photopheresis

7. Technology: Market Size & Analysis
7.1. Overview
7.2. Membrane Filtration
7.3. Centrifugation

8. Method: Market Size & Analysis
8.1. Overview
8.2. Automated Blood Collection
8.3. Therapeutic Apheresis

9. Geography: Market Size & Analysis
9.1. Overview
9.2. North America
9.3. Europe
9.4. Asia Pacific
9.5. Rest of the World

10. Competitive Landscape
10.1. Competitor Comparison Analysis
10.2. Market Developments
10.3. Mergers and Acquisitions, Legal, Awards, Partnerships
10.4. Product Launches and execution

11. Vendor Profiles
11.1. Mallinckrodt Plc
11.1.1. Overview
11.1.2. Product Offerings
11.1.3. Geographic Revenue
11.1.4. Business Units
11.1.5. Developments
11.1.6. SWOT Analysis
11.1.7. Business Strategy
11.2. Medicap Clinic GmbH
11.2.1. Overview
11.2.2. Product Offerings
11.2.3. Geographic Revenue
11.2.4. Business Units
11.2.5. Developments
11.2.6. SWOT Analysis
11.2.7. Business Strategy
11.3. LMB Technologie GmbH
11.3.1. Overview
11.3.2. Product Offerings
11.3.3. Geographic Revenue
11.3.4. Business Units
11.3.5. Developments
11.3.6. SWOT Analysis
11.3.7. Business Strategy
11.4. Bioelettronica Srl
11.4.1. Overview
11.4.2. Product Offerings
11.4.3. Geographic Revenue
11.4.4. Business Units
11.4.5. Developments
11.4.6. SWOT Analysis
11.4.7. Business Strategy
11.5. Infomed
11.5.1. Overview
11.5.2. Product Offerings
11.5.3. Geographic Revenue
11.5.4. Business Units
11.5.5. Developments
11.5.6. SWOT Analysis
11.5.7. Business Strategy
11.6. B. Braun Melsungen AG
11.6.1. Overview
11.6.2. Product Offerings
11.6.3. Geographic Revenue
11.6.4. Business Units
11.6.5. Developments
11.6.6. SWOT Analysis
11.6.7. Business Strategy
11.7. Cerus Corporation
11.7.1. Overview
11.7.2. Product Offerings
11.7.3. Geographic Revenue
11.7.4. Business Units
11.7.5. Developments
11.7.6. SWOT Analysis
11.7.7. Business Strategy
11.8. Kaneka Corporation
11.8.1. Overview
11.8.2. Product Offerings
11.8.3. Geographic Revenue
11.8.4. Business Units
11.8.5. Developments
11.8.6. SWOT Analysis
11.8.7. Business Strategy
11.9. Kawasumi Laboratories, Inc.
11.9.1. Overview
11.9.2. Product Offerings
11.9.3. Geographic Revenue
11.9.4. Business Units
11.9.5. Developments
11.9.6. SWOT Analysis
11.9.7. Business Strategy
11.10. Nikkiso Co., Ltd.
11.10.1. Overview
11.10.2. Product Offerings
11.10.3. Geographic Revenue
11.10.4. Business Units
11.10.5. Developments
11.10.6. SWOT Analysis
11.10.7. Business Strategy

12. Companies to Watch
12.1. Macopharma SA
12.1.1. Overview
12.1.2. Market
12.1.3. Business Strategy
12.2. Miltenyi Biotec
12.2.1. Overview
12.2.2. Market
12.2.3. Business Strategy
12.3. Otsuka Holdings Co., Ltd.
12.3.1. Overview
12.3.2. Market
12.3.3. Business Strategy
12.4. Medica Spa
12.4.1. Overview
12.4.2. Market
12.4.3. Business Strategy
12.5. Cytosorbents Corporation
12.5.1. Overview
12.5.2. Market
12.5.3. Business Strategy
12.6. Toray Medical Co., Ltd.
12.6.1. Overview
12.6.2. Market
12.6.3. Business Strategy
12.7. Terumo BCT, Inc.
12.7.1. Overview
12.7.2. Market
12.7.3. Business Strategy
12.8. Fresenius Se & Co. KGaA
12.8.1. Overview
12.8.2. Market
12.8.3. Business Strategy
12.9. Haemonetics Corporation
12.9.1. Overview
12.9.2. Market
12.9.3. Business Strategy
12.10. Baxter International Inc.
12.10.1. Overview
12.10.2. Market
12.10.3. Business Strategy
12.11. Asahi Kasei Medical Co. Ltd
12.11.1. Overview
12.11.2. Market
12.11.3. Business Strategy

13. Analyst Opinion

14. Annexure
14.1. Report Scope
14.2. Market Definitions
14.3. Research Methodology
14.3.1. Data Collation and In-house Estimation
14.3.2. Market Triangulation
14.3.3. Forecasting
14.4. Report Assumptions
14.5. Declarations
14.6. Stakeholders
14.7. Abbreviations

List of Tables
TABLE 1. GLOBAL APHERESIS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 2. GLOBAL APHERESIS MARKET VALUE FOR DEVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 3. GLOBAL APHERESIS MARKET VALUE FOR DISPOSABLES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 4. GLOBAL APHERESIS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 5. GLOBAL APHERESIS MARKET VALUE FOR PLASMAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 6. GLOBAL APHERESIS MARKET VALUE FOR PLATELETPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 7. GLOBAL APHERESIS MARKET VALUE FOR ERYTHROCYTAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 8. GLOBAL APHERESIS MARKET VALUE FOR LEUKAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 9. GLOBAL APHERESIS MARKET VALUE FOR PHOTOPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 10. GLOBAL APHERESIS MARKET VALUE, BY TECHNOLOGY, 2020-2026 (USD BILLION)
TABLE 11. GLOBAL APHERESIS MARKET VALUE FOR MEMBRANE FILTRATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 12. GLOBAL APHERESIS MARKET VALUE FOR CENTRIFUGATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 13. GLOBAL APHERESIS MARKET VALUE, BY METHOD, 2020-2026 (USD BILLION)
TABLE 14. GLOBAL APHERESIS MARKET VALUE FOR AUTOMATED BLOOD COLLECTION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 15. GLOBAL APHERESIS MARKET VALUE FOR THERAPEUTIC APHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 16. NORTH AMERICA APHERESIS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 17. NORTH AMERICA APHERESIS MARKET VALUE FOR DEVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 18. NORTH AMERICA APHERESIS MARKET VALUE FOR DISPOSABLES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 19. NORTH AMERICA APHERESIS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 20. NORTH AMERICA APHERESIS MARKET VALUE FOR PLASMAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 21. NORTH AMERICA APHERESIS MARKET VALUE FOR PLATELETPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 22. NORTH AMERICA APHERESIS MARKET VALUE FOR ERYTHROCYTAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 23. NORTH AMERICA APHERESIS MARKET VALUE FOR LEUKAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 24. NORTH AMERICA APHERESIS MARKET VALUE FOR PHOTOPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 25. NORTH AMERICA APHERESIS MARKET VALUE, BY TECHNOLOGY, 2020-2026 (USD BILLION)
TABLE 26. NORTH AMERICA APHERESIS MARKET VALUE FOR MEMBRANE FILTRATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 27. NORTH AMERICA APHERESIS MARKET VALUE FOR CENTRIFUGATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 28. NORTH AMERICA APHERESIS MARKET VALUE, BY METHOD, 2020-2026 (USD BILLION)
TABLE 29. NORTH AMERICA APHERESIS MARKET VALUE FOR AUTOMATED BLOOD COLLECTION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 30. NORTH AMERICA APHERESIS MARKET VALUE FOR THERAPEUTIC APHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 31. EUROPE APHERESIS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 32. EUROPE APHERESIS MARKET VALUE FOR DEVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 33. EUROPE APHERESIS MARKET VALUE FOR DISPOSABLES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 34. EUROPE APHERESIS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 35. EUROPE APHERESIS MARKET VALUE FOR PLASMAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 36. EUROPE APHERESIS MARKET VALUE FOR PLATELETPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 37. EUROPE APHERESIS MARKET VALUE FOR ERYTHROCYTAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 38. EUROPE APHERESIS MARKET VALUE FOR LEUKAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 39. EUROPE APHERESIS MARKET VALUE FOR PHOTOPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 40. EUROPE APHERESIS MARKET VALUE, BY TECHNOLOGY, 2020-2026 (USD BILLION)
TABLE 41. EUROPE APHERESIS MARKET VALUE FOR MEMBRANE FILTRATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 42. EUROPE APHERESIS MARKET VALUE FOR CENTRIFUGATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 43. EUROPE APHERESIS MARKET VALUE, BY METHOD, 2020-2026 (USD BILLION)
TABLE 44. EUROPE APHERESIS MARKET VALUE FOR AUTOMATED BLOOD COLLECTION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 45. EUROPE APHERESIS MARKET VALUE FOR THERAPEUTIC APHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 46. ASIA PACIFIC APHERESIS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 47. ASIA PACIFC APHERESIS MARKET VALUE FOR DEVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 48. ASIA PACIFC APHERESIS MARKET VALUE FOR DISPOSABLES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 49. ASIA PACIFC APHERESIS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 50. ASIA PACIFC APHERESIS MARKET VALUE FOR PLASMAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 51. ASIA PACIFC APHERESIS MARKET VALUE FOR PLATELETPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 52. ASIA PACIFC APHERESIS MARKET VALUE FOR ERYTHROCYTAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 53. ASIA PACIFC APHERESIS MARKET VALUE FOR LEUKAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 54. ASIA PACIFC APHERESIS MARKET VALUE FOR PHOTOPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 55. ASIA PACIFC APHERESIS MARKET VALUE, BY TECHNOLOGY, 2020-2026 (USD BILLION)
TABLE 56. ASIA PACIFC APHERESIS MARKET VALUE FOR MEMBRANE FILTRATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 57. ASIA PACIFC APHERESIS MARKET VALUE FOR CENTRIFUGATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 58. ASIA PACIFC APHERESIS MARKET VALUE, BY METHOD, 2020-2026 (USD BILLION)
TABLE 59. ASIA PACIFC APHERESIS MARKET VALUE FOR AUTOMATED BLOOD COLLECTION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 60. ASIA PACIFC APHERESIS MARKET VALUE FOR THERAPEUTIC APHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 61. REST OF WORLD APHERESIS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 62. REST OF WORLD APHERESIS MARKET VALUE FOR DEVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 63. REST OF WORLD APHERESIS MARKET VALUE FOR DISPOSABLES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 64. REST OF WORLD APHERESIS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 65. REST OF WORLD APHERESIS MARKET VALUE FOR PLASMAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 66. REST OF WORLD APHERESIS MARKET VALUE FOR PLATELETPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 67. REST OF WORLD APHERESIS MARKET VALUE FOR ERYTHROCYTAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 68. REST OF WORLD APHERESIS MARKET VALUE FOR LEUKAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 69. REST OF WORLD APHERESIS MARKET VALUE FOR PHOTOPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 70. REST OF WORLD APHERESIS MARKET VALUE, BY TECHNOLOGY, 2020-2026 (USD BILLION)
TABLE 71. REST OF WORLD APHERESIS MARKET VALUE FOR MEMBRANE FILTRATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 72. REST OF WORLD APHERESIS MARKET VALUE FOR CENTRIFUGATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 73. REST OF WORLD APHERESIS MARKET VALUE, BY METHOD, 2020-2026 (USD BILLION)
TABLE 74. REST OF WORLD APHERESIS MARKET VALUE FOR AUTOMATED BLOOD COLLECTION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 75. REST OF WORLD APHERESIS MARKET VALUE FOR THERAPEUTIC APHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 76. MALLINCKRODT PLC: OVERVIEW
TABLE 77. MALLINCKRODT PLC: STRATEGIC SNAPSHOT
TABLE 78. MALLINCKRODT PLC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 79. MALLINCKRODT PLC: PRODUCT/SERVICE PORTFOLIO
TABLE 80. MEDICAP CLINIC GMBH: OVERVIEW
TABLE 81. MEDICAP CLINIC GMBH: STRATEGIC SNAPSHOT
TABLE 82. MEDICAP CLINIC GMBH: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 83. MEDICAP CLINIC GMBH: PRODUCT/SERVICE PORTFOLIO
TABLE 84. LMB TECHNOLOGIE GMBH: OVERVIEW
TABLE 85. LMB TECHNOLOGIE GMBH: STRATEGIC SNAPSHOT
TABLE 86. LMB TECHNOLOGIE GMBH: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 87. LMB TECHNOLOGIE GMBH: PRODUCT/SERVICE PORTFOLIO
TABLE 88. BIOELETTRONICA SRL: OVERVIEW
TABLE 89. BIOELETTRONICA SRL: STRATEGIC SNAPSHOT
TABLE 90. BIOELETTRONICA SRL: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 91. BIOELETTRONICA SRL: PRODUCT/SERVICE PORTFOLIO
TABLE 92. INFOMED: OVERVIEW
TABLE 93. INFOMED: STRATEGIC SNAPSHOT
TABLE 94. INFOMED: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 95. INFOMED: PRODUCT/SERVICE PORTFOLIO
TABLE 96. B. BRAUN MELSUNGEN AG: OVERVIEW
TABLE 97. B. BRAUN MELSUNGEN AG: STRATEGIC SNAPSHOT
TABLE 98. B. BRAUN MELSUNGEN AG: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 99. B. BRAUN MELSUNGEN AG: PRODUCT/SERVICE PORTFOLIO
TABLE 100. CERUS CORPORATION: OVERVIEW
TABLE 101. CERUS CORPORATION: STRATEGIC SNAPSHOT
TABLE 102. CERUS CORPORATION: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 103. CERUS CORPORATION: PRODUCT/SERVICE PORTFOLIO
TABLE 104. KANEKA CORPORATION: OVERVIEW
TABLE 105. KANEKA CORPORATION: STRATEGIC SNAPSHOT
TABLE 106. KANEKA CORPORATION: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 107. KANEKA CORPORATION: PRODUCT/SERVICE PORTFOLIO
TABLE 108. KAWASUMI LABORATORIES, INC: OVERVIEW
TABLE 109. KAWASUMI LABORATORIES, INC: STRATEGIC SNAPSHOT
TABLE 110. KAWASUMI LABORATORIES, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 111. KAWASUMI LABORATORIES, INC: PRODUCT/SERVICE PORTFOLIO
TABLE 112. NIKKISO CO., LTD: OVERVIEW
TABLE 113. NIKKISO CO., LTD: STRATEGIC SNAPSHOT
TABLE 114. NIKKISO CO., LTD: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 115. NIKKISO CO., LTD: PRODUCT/SERVICE PORTFOLIO

List of Figures
CHART. 1. GLOBAL APHERESIS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 2. GLOBAL APHERESIS MARKET VALUE FOR DEVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 3. GLOBAL APHERESIS MARKET VALUE FOR DISPOSABLES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 4. GLOBAL APHERESIS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 5. GLOBAL APHERESIS MARKET VALUE FOR PLASMAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 6. GLOBAL APHERESIS MARKET VALUE FOR PLATELETPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 7. GLOBAL APHERESIS MARKET VALUE FOR ERYTHROCYTAPHERESIS, BY GEOGRAPHY, 2020- 2026 (USD BILLION)
CHART. 8. GLOBAL APHERESIS MARKET VALUE FOR LEUKAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 9. GLOBAL APHERESIS MARKET VALUE FOR PHOTOPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 10. GLOBAL APHERESIS MARKET VALUE, BY TECHNOLOGY, 2020-2026 (USD BILLION)
CHART. 11. GLOBAL APHERESIS MARKET VALUE FOR MEMBRANE FILTRATION, BY GEOGRAPHY, 2020- 2026 (USD BILLION)
CHART. 12. GLOBAL APHERESIS MARKET VALUE FOR CENTRIFUGATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 13. GLOBAL APHERESIS MARKET VALUE, BY METHOD, 2020-2026 (USD BILLION)
CHART. 14. GLOBAL APHERESIS MARKET VALUE FOR AUTOMATED BLOOD COLLECTION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 15. GLOBAL APHERESIS MARKET VALUE FOR THERAPEUTIC APHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 16. NORTH AMERICA APHERESIS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 17. NORTH AMERICA APHERESIS MARKET VALUE FOR DEVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 18. NORTH AMERICA APHERESIS MARKET VALUE FOR DISPOSABLES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 19. NORTH AMERICA APHERESIS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 20. NORTH AMERICA APHERESIS MARKET VALUE FOR PLASMAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 21. NORTH AMERICA APHERESIS MARKET VALUE FOR PLATELETPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 22. NORTH AMERICA APHERESIS MARKET VALUE FOR ERYTHROCYTAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 23. NORTH AMERICA APHERESIS MARKET VALUE FOR LEUKAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 24. NORTH AMERICA APHERESIS MARKET VALUE FOR PHOTOPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 25. NORTH AMERICA APHERESIS MARKET VALUE, BY TECHNOLOGY, 2020-2026 (USD BILLION)
CHART. 26. NORTH AMERICA APHERESIS MARKET VALUE FOR MEMBRANE FILTRATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 27. NORTH AMERICA APHERESIS MARKET VALUE FOR CENTRIFUGATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 28. NORTH AMERICA APHERESIS MARKET VALUE, BY METHOD, 2020-2026 (USD BILLION)
CHART. 29. NORTH AMERICA APHERESIS MARKET VALUE FOR AUTOMATED BLOOD COLLECTION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 30. NORTH AMERICA APHERESIS MARKET VALUE FOR THERAPEUTIC APHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 31. EUROPE APHERESIS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 32. EUROPE APHERESIS MARKET VALUE FOR DEVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 33. EUROPE APHERESIS MARKET VALUE FOR DISPOSABLES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 34. EUROPE APHERESIS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 35. EUROPE APHERESIS MARKET VALUE FOR PLASMAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 36. EUROPE APHERESIS MARKET VALUE FOR PLATELETPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 37. EUROPE APHERESIS MARKET VALUE FOR ERYTHROCYTAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 38. EUROPE APHERESIS MARKET VALUE FOR LEUKAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 39. EUROPE APHERESIS MARKET VALUE FOR PHOTOPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 40. EUROPE APHERESIS MARKET VALUE, BY TECHNOLOGY, 2020-2026 (USD BILLION)
CHART. 41. EUROPE APHERESIS MARKET VALUE FOR MEMBRANE FILTRATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 42. EUROPE APHERESIS MARKET VALUE FOR CENTRIFUGATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 43. EUROPE APHERESIS MARKET VALUE, BY METHOD, 2020-2026 (USD BILLION)
CHART. 44. EUROPE APHERESIS MARKET VALUE FOR AUTOMATED BLOOD COLLECTION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 45. EUROPE APHERESIS MARKET VALUE FOR THERAPEUTIC APHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 46. ASIA PACIFIC APHERESIS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 47. ASIA PACIFC APHERESIS MARKET VALUE FOR DEVICES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 48. ASIA PACIFC APHERESIS MARKET VALUE FOR DISPOSABLES, BY GEOGRAPHY, 2020-2026(USD BILLION)
CHART. 49. ASIA PACIFC APHERESIS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 50. ASIA PACIFC APHERESIS MARKET VALUE FOR PLASMAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 51. ASIA PACIFC APHERESIS MARKET VALUE FOR PLATELETPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 52. ASIA PACIFC APHERESIS MARKET VALUE FOR ERYTHROCYTAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 53. ASIA PACIFC APHERESIS MARKET VALUE FOR LEUKAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 54. ASIA PACIFC APHERESIS MARKET VALUE FOR PHOTOPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 55. ASIA PACIFC APHERESIS MARKET VALUE, BY TECHNOLOGY, 2020-2026 (USD BILLION)
CHART. 56. ASIA PACIFC APHERESIS MARKET VALUE FOR MEMBRANE FILTRATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 57. ASIA PACIFC APHERESIS MARKET VALUE FOR CENTRIFUGATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 58. ASIA PACIFC APHERESIS MARKET VALUE, BY METHOD, 2020-2026 (USD BILLION)
CHART. 59. ASIA PACIFC APHERESIS MARKET VALUE FOR AUTOMATED BLOOD COLLECTION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 60. ASIA PACIFC APHERESIS MARKET VALUE FOR THERAPEUTIC APHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 61. REST OF WORLD APHERESIS MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 62. REST OF WORLD APHERESIS MARKET VALUE FOR DEVICES, BY GEOGRAPHY, 2020-2026(USD BILLION)
CHART. 63. REST OF WORLD APHERESIS MARKET VALUE FOR DISPOSABLES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 64. REST OF WORLD APHERESIS MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 65. REST OF WORLD APHERESIS MARKET VALUE FOR PLASMAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 66. REST OF WORLD APHERESIS MARKET VALUE FOR PLATELETPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 67. REST OF WORLD APHERESIS MARKET VALUE FOR ERYTHROCYTAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 68. REST OF WORLD APHERESIS MARKET VALUE FOR LEUKAPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 69. REST OF WORLD APHERESIS MARKET VALUE FOR PHOTOPHERESIS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 70. REST OF WORLD APHERESIS MARKET VALUE, BY TECHNOLOGY, 2020-2026 (USD BILLION)
CHART. 71. REST OF WORLD APHERESIS MARKET VALUE FOR MEMBRANE FILTRATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 72. REST OF WORLD APHERESIS MARKET VALUE FOR CENTRIFUGATION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 73. REST OF WORLD APHERESIS MARKET VALUE, BY METHOD, 2020-2026 (USD BILLION)
CHART. 74. REST OF WORLD APHERESIS MARKET VALUE FOR AUTOMATED BLOOD COLLECTION, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 75. REST OF WORLD APHERESIS MARKET VALUE FOR THERAPEUTIC APHERESIS, BYn GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 76. MALLINCKRODT PLC: SWOT ANALYSIS
CHART. 77. MEDICAP CLINIC GMBH: SWOT ANALYSIS
CHART. 78. LMB TECHNOLOGIE GMBH: SWOT ANALYSIS
CHART. 79. BIOELETTRONICA SRL: SWOT ANALYSIS
CHART. 80. INFOMED: SWOT ANALYSIS
CHART. 81. B. BRAUN MELSUNGEN AG: SWOT ANALYSIS
CHART. 82. CERUS CORPORATION: SWOT ANALYSIS
CHART. 83. KANEKA CORPORATION: SWOT ANALYSIS
CHART. 84. KAWASUMI LABORATORIES, INC: SWOT ANALYSIS
CHART. 85. NIKKISO CO., LTD: SWOT ANALYSIS

Note: Product cover images may vary from those shown
3 of 3
  • Asahi Kasei Medical Co. Ltd
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bioelettronica Srl
  • Cerus Corporation
  • Cytosorbents Corporation
  • Fresenius Se & Co. KGaA
  • Haemonetics Corporation
  • Infomed
  • Kaneka Corporation
  • Kawasumi Laboratories, Inc.
  • LMB Technologie GmbH
  • Macopharma SA
  • Mallinckrodt Plc
  • Medica Spa
  • Medicap Clinic GmbH
  • Miltenyi Biotec
  • Nikkiso Co., Ltd.
  • Otsuka Holdings Co., Ltd.
  • Terumo BCT, Inc.
  • Toray Medical Co., Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll